US Patent 7196201 Pyrrolidines as dipeptidyl peptidase inhibitors
Patent 7196201 was granted and assigned to Smithkline Beecham Limited on March, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 6 Sep, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Amarjit Sab Randhawa0
Curt Dale Haffner0
Darryl Lynn McDougald0
David N Deaton0
Steven Michael Reister0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+245 characters)
Article
Patent abstract
The present invention relates to novel compounds, their use for inhibiting serine proteases, such as dipeptidyl peptidases, such as dipeptidyl peptidase IV (DPP-IV) and to methods for their production and their therapeutic utility
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07196201 Pyrrolidines as dipeptidyl peptidase inhibitors US Patent 7196201 Pyrrolidines as dipeptidyl peptidase inhibitors
Infobox
Patent Number
071962010
Patent Number
71962010
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071962010
Date of Patent
March 27, 2007
0Patent Application Number
104812880
Date Filed
June 26, 2002
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 20 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07196201 Pyrrolidines as dipeptidyl peptidase inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07196201
Date of patent
March 27, 2007
Patent application number
10481288
Date Filed
June 26, 2002
Patent primary examiner
Find more entities like US Patent 7196201 Pyrrolidines as dipeptidyl peptidase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.